Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0100191136
Fri, 28.04.2023       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders 28.04.2023 / 19:00 CET/CEST Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders Shareholders approved all proposals by a large majority; Company to effectu [ … ]
Technical analysis
To the publication
Thu, 16.03.2023       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe 16.03.2023 / 07:00 CET/CEST  Relief Therapeutics Announces Availability of New PKU GOLIKE BARs® in Europe The Company also discloses it has transferred most of the funds it held with Credit Sui [ … ]
Technical analysis
To the publication
Thu, 16.03.2023       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe 16.03.2023 / 07:00 CET/CEST  Relief Therapeutics Announces Availability of New PKU GOLIKE BARs® in Europe The Company also discloses it has transferred most of the funds it held with Credit Sui [ … ]
Technical analysis
To the publication
Tue, 28.02.2023       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars 28.02.2023 / 07:00 CET/CEST Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE® Bars Paolo Galfetti, chief operating of [ … ]
Technical analysis
To the publication
Tue, 28.02.2023       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars 28.02.2023 / 07:00 CET/CEST Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE® Bars Paolo Galfetti, chief operating of [ … ]
Technical analysis
To the publication
Wed, 14.12.2022       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in January Investor Meetings 14.12.2022 / 07:00 CET/CEST Relief Therapeutics to Participate in January Investor Meetings GENEVA, DEC. 14, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (“Relief”), a Swiss, commerci [ … ]
Technical analysis
To the publication
Wed, 14.12.2022       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in January Investor Meetings 14.12.2022 / 07:00 CET/CEST Relief Therapeutics to Participate in January Investor Meetings GENEVA, DEC. 14, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (“Relief”), a Swiss, commerci [ … ]
Technical analysis
To the publication
Mon, 21.11.2022       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Miscellaneous APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival 21.11.2022 / 07:00 CET/CEST APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease Inter [ … ]
Technical analysis
To the publication
Mon, 21.11.2022       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Miscellaneous APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival 21.11.2022 / 07:00 CET/CEST APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease Inter [ … ]
Technical analysis
To the publication
Mon, 12.09.2022       Relief Therapeutics Holding SA
CH0100191136

Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum 12.09.2022 / 07:05 CET/CEST Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe ForumGeneva, Switzerland, September 12, 2022 – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 06.10.2024, Calendar Week 40, 280th day of the year, 86 days remaining until EoY.